Editor’s note. I’ve twice written about Timothy Atchison, the first patient to receive an infusion of a drug made of human embryonic stem cells, who for his own reasons decided to reveal his identity to a Washington Post reporter. The following, from the blog of...
Misinformation, poor thinking in an age of biotechnology
read more